유럽, 코로나19 급증…미국 일평균 확진 6만 명 근접<br /><br />Moving on to the COVID-19 situation worldwide.<br />Things are beginning to deteriorate in Europe,... and there are predictions from health experts that the U.S. will also experience a spike of daily COVID-19 cases in a week or two.<br />Meanwhile, a first death has been reported from a clinical trial for COVID-19 vaccine.<br />Jang Tae-hyun reports.<br />The total number of COVID-19 cases globally surpassed 41 million on Thursday.<br />And according to the Johns Hopkins University, the coronavirus has killed more than one-point-one million people around the world.<br />The situation in Europe in particular is beginning to worsen.<br />A surge in daily cases of COVID-19 has forced some countries to impose lockdowns.<br />Belgium could impose a lockdown of its own next weekend if the situation hasn't improved.<br />Curfews were put in place on Monday while restaurants and cafes have been closed completely.<br />Meanwhile, Spain on Wednesday became the first country in Western Europe to surpass one million confirmed cases.<br />Lockdown was imposed early this year, but after restrictions were eased, numbers began to surge.<br />Over the past week in the U.S., there has been a daily average of around 60-thousand new cases.<br />Health experts say that after one to two weeks, daily figures can spike even further throughout fall and winter.<br />U.S. health officials on Wednesday added the term "multiple and brief exposures" to its definition of close contact with someone infected with COVID-19.<br />"Individuals who had a series of shorter contacts, but over time added up to more than 15 minutes became infected."<br />A first death has been reported from a COVID-19 vaccine trial.<br />Brazil's health agency, Anvisa, said Wednesday that a participant in a clinical trial of a vaccine developed by AstraZeneca and Oxford University has died, but the trial would resume.<br />It has been reported that the person in question was in the control group and wasn't given a dose of the experimental vaccine.<br />Jang Tae-hyun, Arirang News.<br />
